Immunoclin (Immunoclin) EBITDA Margin % : -15,540.00% (As of Oct. 2014)

Immunoclin EBITDA Margin % Chart

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
EBITDA Margin %	Get a 7-Day Free Trial									-	-	-	-	-15,540.00

Competitive Comparison of Immunoclin's EBITDA Margin %

For the Biotechnology subindustry, Immunoclin's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunoclin's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunoclin's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Immunoclin's EBITDA Margin % falls into.

Immunoclin EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Immunoclin's EBITDA Margin % for the fiscal year that ended in Jan. 2014 is calculated as

Immunoclin's EBITDA Margin % for the quarter that ended in Oct. 2014 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunoclin  (GREY:IMCL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Immunoclin EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Immunoclin's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description